General Information
NuSirt NS-200
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Two Fixed-Dose Leucine, Metformin and Sildenafil Combinations (NS-0200) Versus Placebo on Hepatic Fat Content Assessed by Proton-Density-Fat-Fraction in Patients with Non-Alcoholic Fatty Liver Disease.
| Protocol | NS-200 |
|---|---|
| Identifier | Site No: 06 |
| UID | 9f27db92-43e0-4597-bd0b-02d9a6ec78af |
| Status | Done - Archived |
| Phase | 2a |
| Category | Fatty Liver / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-05-15 11:32 |
| Last Updated | 2015-05-15 11:32 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | 2015-11-19 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-11-04 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-11-01 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | - | No | |
| Recruiter | - | No | |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | NuSirt BioPharma |
|---|---|
| Division | NuSirt BioPharma |
| Team | NuSirt BioPharma |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
